Stimuli-sensitive nanopreparations for combination cancer therapy.
暂无分享,去创建一个
Vladimir Torchilin | Aditi Jhaveri | V. Torchilin | Aditi Jhaveri | Pranali P. Deshpande | Pranali Deshpande
[1] C. Gialeli,et al. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting , 2011, The FEBS journal.
[2] M. Repka,et al. Matrix metalloproteinase-sensitive thermogelling polymer for bioresponsive local drug delivery. , 2011, Acta biomaterialia.
[3] Kazunori Kataoka,et al. Dendrimer phthalocyanine-encapsulated polymeric micelle-mediated photochemical internalization extends the efficacy of photodynamic therapy and overcomes drug-resistance in vivo. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[4] Jun Gao,et al. PEGylated fullerene/iron oxide nanocomposites for photodynamic therapy, targeted drug delivery and MR imaging. , 2013, Biomaterials.
[5] V. Torchilin,et al. Development of the novel PEG-PE-based polymer for the reversible attachment of specific ligands to liposomes: synthesis and in vitro characterization. , 2011, Bioconjugate chemistry.
[6] K. Ng,et al. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery. , 2013, Chemistry.
[7] Paula T Hammond,et al. Layer-by-layer nanoparticles for systemic codelivery of an anticancer drug and siRNA for potential triple-negative breast cancer treatment. , 2013, ACS nano.
[8] Junsheng Liu,et al. Formation of thermo-sensitive polyelectrolyte complex micelles from two biocompatible graft copolymers for drug delivery. , 2014, Journal of biomedical materials research. Part A.
[9] Thomas L Andresen,et al. Enzyme-triggered nanomedicine: Drug release strategies in cancer therapy (Invited Review) , 2010, Molecular membrane biology.
[10] Chaoliang He,et al. Co-delivery of 10-hydroxycamptothecin with doxorubicin conjugated prodrugs for enhanced anticancer efficacy. , 2013, Macromolecular bioscience.
[11] R. Langer,et al. Photoswitchable Nanoparticles for Triggered Tissue Penetration and Drug Delivery , 2012, Journal of the American Chemical Society.
[12] T. Yin,et al. cRGD-functionalized polymeric magnetic nanoparticles as a dual-drug delivery system for safe targeted cancer therapy. , 2013, Pharmacological research.
[13] Yaping Li,et al. Overcoming multidrug resistance by co-delivery of Mdr-1 and survivin-targeting RNA with reduction-responsible cationic poly(β-amino esters). , 2012, Biomaterials.
[14] San-Yuan Chen,et al. Enhancement of cancer therapy efficacy by trastuzumab-conjugated and pH-sensitive nanocapsules with the simultaneous encapsulation of hydrophilic and hydrophobic compounds. , 2014, Nanomedicine : nanotechnology, biology, and medicine.
[15] C. Alexander,et al. Stimuli responsive polymers for biomedical applications. , 2005, Chemical Society reviews.
[16] G. Murphy. The ADAMs: signalling scissors in the tumour microenvironment , 2008, Nature Reviews Cancer.
[17] Afsaneh Lavasanifar,et al. Traceable multifunctional micellar nanocarriers for cancer-targeted co-delivery of MDR-1 siRNA and doxorubicin. , 2011, ACS nano.
[18] Laurence Raehm,et al. Cancer therapy improvement with mesoporous silica nanoparticles combining targeting, drug delivery and PDT. , 2012, International journal of pharmaceutics.
[19] Jean-Pierre Gillet,et al. Mechanisms of multidrug resistance in cancer. , 2010, Methods in molecular biology.
[20] Morteza Mahmoudi,et al. Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles. , 2011, Advances in colloid and interface science.
[21] Lin Zhu,et al. Stimulus-responsive nanopreparations for tumor targeting. , 2013, Integrative biology : quantitative biosciences from nano to macro.
[22] D. Panagiotakos,et al. Increased temperature of malignant urinary bladder tumors in vivo: the application of a new method based on a catheter technique. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] L. Huang,et al. Highly efficient DNA delivery mediated by pH-sensitive immunoliposomes. , 1989, Biochemistry.
[24] R. Jain,et al. Photodynamic therapy for cancer , 2003, Nature Reviews Cancer.
[25] Adah Almutairi,et al. Photochemical mechanisms of light-triggered release from nanocarriers. , 2012, Advanced drug delivery reviews.
[26] N. P. Ulrih,et al. Multifunctional superparamagnetic iron oxide nanoparticles: promising tools in cancer theranostics. , 2013, Cancer letters.
[27] J. Foidart,et al. Emerging roles of ADAM and ADAMTS metalloproteinases in cancer. , 2008, Biochimie.
[28] Baorui Liu,et al. Novel thermosensitive polymeric micelles for docetaxel delivery. , 2007, Journal of biomedical materials research. Part A.
[29] Jianping Zhou,et al. Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel. , 2012, Biomaterials.
[30] B. Al-Lazikani,et al. Combinatorial drug therapy for cancer in the post-genomic era , 2012, Nature Biotechnology.
[31] Zhiyuan Zhong,et al. Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[32] Joel A Swanson,et al. Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities. , 2003, Advanced drug delivery reviews.
[33] Makoto Takafuji,et al. Gene delivery into human cancer cells by cationic lipid-mediated magnetofection. , 2013, International journal of pharmaceutics.
[34] G. Salzano,et al. Polymeric micelles containing reversibly phospholipid-modified anti-survivin siRNA: a promising strategy to overcome drug resistance in cancer. , 2014, Cancer letters.
[35] J. Fox,et al. ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3. , 2000, Biochemical and biophysical research communications.
[36] C. Janeway,et al. Elevated temperature regulates tumor necrosis factor‐mediated immune killing , 1989, European journal of immunology.
[37] Vladimir Torchilin,et al. Multifunctional and stimuli-sensitive pharmaceutical nanocarriers. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[38] J. Karp,et al. Nanocarriers as an Emerging Platform for Cancer Therapy , 2022 .
[39] I. Safarik,et al. Magnetic Nanoparticles and Biosciences , 2002 .
[40] T. Okano,et al. 20. Multi-targeting system with fusion between thermoresponsive carriers and mild hyperthermia: Original research article: Thermo-responsive drug delivery from polymeric micelles constructed using block copolymers of poly(N-isopropylacrylamide) and poly(butylmethacrylate) (1999). , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[41] Chandana Mohanty,et al. Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy. , 2010, Biomaterials.
[42] T. Andresen,et al. Liposomes containing alkylated methotrexate analogues for phospholipase A(2) mediated tumor targeted drug delivery. , 2009, Chemistry and physics of lipids.
[43] Kazuo Maruyama,et al. Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects. , 2011, Advanced drug delivery reviews.
[44] L. Gerweck,et al. Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. , 1996, Cancer research.
[45] Ting-Chao Chou,et al. Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies , 2006, Pharmacological Reviews.
[46] Liang Shen,et al. Triplet excited state characters and photosensitization mechanisms of alpha-terthienyl: a theoretical study. , 2009, Journal of photochemistry and photobiology. B, Biology.
[47] Yaping Li,et al. Reversal of lung cancer multidrug resistance by pH-responsive micelleplexes mediating co-delivery of siRNA and paclitaxel. , 2014, Macromolecular bioscience.
[48] A. Hoffman,et al. Efficient Intracellular Delivery of a Pro-Apoptotic Peptide With A pH-Responsive Carrier. , 2011, Reactive & functional polymers.
[49] S. Mallapragada,et al. Injectable self-assembled block copolymers for sustained gene and drug co-delivery: an in vitro study. , 2012, International journal of pharmaceutics.
[50] H. Uno,et al. Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999. , 2010, Blood.
[51] X. Jing,et al. Co-delivery of daunomycin and oxaliplatin by biodegradable polymers for safer and more efficacious combination therapy. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[52] Bonnie F. Sloane,et al. Cathepsin B and its role(s) in cancer progression. , 2003, Biochemical Society symposium.
[53] Liangfang Zhang,et al. Nanoparticle-assisted combination therapies for effective cancer treatment. , 2010, Therapeutic delivery.
[54] F. Kiessling,et al. Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[55] Benedict Law,et al. Release of liposomal contents by cell-secreted matrix metalloproteinase-9. , 2009, Bioconjugate chemistry.
[56] J. Foidart,et al. Higher sensitivity of Adamts12-deficient mice to tumor growth and angiogenesis , 2010, Oncogene.
[57] Bonnie F. Sloane,et al. Cysteine cathepsins in human cancer , 2004, Biological chemistry.
[58] G. Balendiran,et al. The role of glutathione in cancer , 2004, Cell biochemistry and function.
[59] Z. Werb,et al. Matrix Metalloproteinases: Regulators of the Tumor Microenvironment , 2010, Cell.
[60] P. Ruff,et al. A randomized, placebo-controlled, double-blind phase 2 study of docetaxel compared to docetaxel plus zosuquidar (LY335979) in women with metastatic or locally recurrent breast cancer who have received one prior chemotherapy regimen , 2009, Cancer Chemotherapy and Pharmacology.
[61] Vladimir P Torchilin,et al. pH-sensitive poly(histidine)-PEG/DSPE-PEG co-polymer micelles for cytosolic drug delivery. , 2013, Biomaterials.
[62] Vladimir P Torchilin,et al. Immunomicelles for advancing personalized therapy. , 2012, Advanced drug delivery reviews.
[63] Véronique Préat,et al. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[64] Srinath Palakurthi,et al. Hyaluronic acid-decorated PLGA-PEG nanoparticles for targeted delivery of SN-38 to ovarian cancer. , 2013, Anticancer research.
[65] H. Gu,et al. Delivering hydrophilic and hydrophobic chemotherapeutics simultaneously by magnetic mesoporous silica nanoparticles to inhibit cancer cells , 2012, International journal of nanomedicine.
[66] R. Haag,et al. Development of enzymatically cleavable prodrugs derived from dendritic polyglycerol. , 2009, Bioorganic & medicinal chemistry letters.
[67] A. Hoffman,et al. pH-sensitive polymers that enhance intracellular drug delivery in vivo. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[68] Tae-Hyun Kim,et al. Multifunctional hybrid nanocarrier: magnetic CNTs ensheathed with mesoporous silica for drug delivery and imaging system. , 2014, ACS applied materials & interfaces.
[69] Yue Zhao. Rational design of light-controllable polymer micelles. , 2007, Chemical record.
[70] U. Sharma,et al. Composite polymeric magnetic nanoparticles for co-delivery of hydrophobic and hydrophilic anticancer drugs and MRI imaging for cancer therapy. , 2011, ACS applied materials & interfaces.
[71] I. Tannock,et al. Acid pH in tumors and its potential for therapeutic exploitation. , 1989, Cancer research.
[72] Stuart S Dunn,et al. Reductively responsive siRNA-conjugated hydrogel nanoparticles for gene silencing. , 2012, Journal of the American Chemical Society.
[73] Robert Blumenthal,et al. A novel class of photo-triggerable liposomes containing DPPC:DC(8,9)PC as vehicles for delivery of doxorubcin to cells. , 2011, Biochimica et biophysica acta.
[74] Andreas Herrmann,et al. Reduction-sensitive liposomes from a multifunctional lipid conjugate and natural phospholipids: reduction and release kinetics and cellular uptake. , 2011, Langmuir : the ACS journal of surfaces and colloids.
[75] G. Bothun,et al. Stimuli-responsive liposome-nanoparticle assemblies , 2011, Expert opinion on drug delivery.
[76] Q. Tong,et al. Co-Delivery of Doxorubicin and SATB1 shRNA by Thermosensitive Magnetic Cationic Liposomes for Gastric Cancer Therapy , 2014, PloS one.
[77] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[78] Z. Gan,et al. Novel reduction-sensitive micelles for triggered intracellular drug release. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[79] J. Ji,et al. Near-infrared light-sensitive micelles for enhanced intracellular drug delivery , 2012 .
[80] N. Zhang,et al. The targeted co-delivery of DNA and doxorubicin to tumor cells via multifunctional PEI-PEG based nanoparticles. , 2013, Biomaterials.
[81] P. Meers,et al. Enzyme-activated targeting of liposomes. , 2001, Advanced drug delivery reviews.
[82] R. Issels,et al. Hyperthermia-induced targeting of thermosensitive gene carriers to tumors. , 2008, Human gene therapy.
[83] K. Na,et al. Endolysosomal environment-responsive photodynamic nanocarrier to enhance cytosolic drug delivery via photosensitizer-mediated membrane disruption. , 2013, Biomaterials.
[84] Patrick Couvreur,et al. Stimuli-responsive nanocarriers for drug delivery. , 2013, Nature materials.
[85] Shirui Mao,et al. Smart pH-sensitive and temporal-controlled polymeric micelles for effective combination therapy of doxorubicin and disulfiram. , 2013, ACS nano.
[86] R. Zhuo,et al. Thermo-triggered and biotinylated biotin-P(NIPAAm-co-HMAAm)-b-PMMA micelles for controlled drug release. , 2009, Journal of biomedical materials research. Part A.
[87] Dibakar Dhara,et al. Thermal and pH responsive polymer-tethered multifunctional magnetic nanoparticles for targeted delivery of anticancer drug. , 2013, ACS applied materials & interfaces.
[88] Vladimir P. Torchilin,et al. Challenges in Development of Targeted Liposomal Therapeutics , 2012, The AAPS Journal.
[89] Freya Q. Schafer,et al. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. , 2001, Free radical biology & medicine.
[90] Dongin Kim,et al. A virus-mimetic nanogel vehicle. , 2008, Angewandte Chemie.
[91] C. van Nostrum,et al. Triggered destabilisation of polymeric micelles and vesicles by changing polymers polarity: an attractive tool for drug delivery. , 2007, Journal of Controlled Release.
[92] D. Thompson,et al. Synthesis of acid-labile diplasmenyl lipids for drug and gene delivery applications. , 1999, Chemistry and physics of lipids.
[93] William Y. Kim,et al. Codelivery of VEGF siRNA and gemcitabine monophosphate in a single nanoparticle formulation for effective treatment of NSCLC. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.
[94] W. Denny,et al. Targeting of nanoparticles in cancer: drug delivery and diagnostics , 2011, Anti-cancer drugs.
[95] Mark W. Dewhirst,et al. Review Hyperthermia and liposomes , 1999 .
[96] Ronit Satchi-Fainaro,et al. Nano-sized polymers and liposomes designed to deliver combination therapy for cancer. , 2013, Current opinion in biotechnology.
[97] T. Okano,et al. Preparation and characterization of thermally responsive block copolymer micelles comprising poly(N-isopropylacrylamide-b-DL-lactide). , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[98] L. Huang,et al. pH-sensitive immunoliposomes as an efficient and target-specific carrier for antitumor drugs. , 1986, Cancer research.
[99] X. Shuai,et al. Co-delivery of doxorubicin and siRNA with reduction and pH dually sensitive nanocarrier for synergistic cancer therapy. , 2014, Small.
[100] H. Maeda,et al. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.
[101] Shiroh Futaki,et al. A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[102] Weiqi Wang,et al. Dual temperature/pH-sensitive drug delivery of poly(N-isopropylacrylamide-co-acrylic acid) nanogels conjugated with doxorubicin for potential application in tumor hyperthermia therapy. , 2011, Colloids and surfaces. B, Biointerfaces.
[103] P. Workman,et al. The combination of cytotoxic and molecularly targeted therapies - can it be done? , 2004 .
[104] K. Kono,et al. Thermosensitive polymer-modified liposomes. , 2001, Advanced drug delivery reviews.
[105] M. Moses,et al. Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[106] Si-Shen Feng,et al. Targeted co-delivery of docetaxel, cisplatin and herceptin by vitamin E TPGS-cisplatin prodrug nanoparticles for multimodality treatment of cancer. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[107] O. Peulen,et al. Nuclear delivery of a therapeutic peptide by long circulating pH-sensitive liposomes: benefits over classical vesicles. , 2011, International journal of pharmaceutics.
[108] Zhiyuan Zhong,et al. Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery. , 2013, Biomaterials.
[109] Alberto Mantovani,et al. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. , 2009, Carcinogenesis.
[110] Ru Cheng,et al. Acetal-linked paclitaxel prodrug micellar nanoparticles as a versatile and potent platform for cancer therapy. , 2013, Biomacromolecules.
[111] T. Okano,et al. Thermo-responsive drug delivery from polymeric micelles constructed using block copolymers of poly(N-isopropylacrylamide) and poly(butylmethacrylate). , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[112] V. Torchilin,et al. Environment-responsive multifunctional liposomes. , 2010, Methods in molecular biology.
[113] Angela C Cruciano,et al. Redox-triggered contents release from liposomes. , 2008, Journal of the American Chemical Society.
[114] T. Yap,et al. Development of therapeutic combinations targeting major cancer signaling pathways. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[115] Molly M Stevens,et al. Enzyme-responsive nanoparticles for drug release and diagnostics. , 2012, Advanced drug delivery reviews.
[116] James H. Doroshow,et al. Utilizing targeted cancer therapeutic agents in combination: novel approaches and urgent requirements , 2010, Nature Reviews Drug Discovery.
[117] F. Ungaro,et al. Biodegradable core-shell nanoassemblies for the delivery of docetaxel and Zn(II)-phthalocyanine inspired by combination therapy for cancer. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[118] Ashutosh Chilkoti,et al. Targeted drug delivery by thermally responsive polymers. , 2002, Advanced drug delivery reviews.
[119] F. Szoka,et al. Acid-triggered transformation of diortho ester phosphocholine liposome. , 2006, Journal of the American Chemical Society.
[120] M. Stack,et al. Proteinase requirements of epidermal growth factor–induced ovarian cancer cell invasion , 1998, International journal of cancer.
[121] Gert Storm,et al. Polymeric Micelles in Anticancer Therapy: Targeting, Imaging and Triggered Release , 2010, Pharmaceutical Research.
[122] Yolonda L Colson,et al. Biologically Responsive Polymeric Nanoparticles for Drug Delivery , 2012, Advanced materials.
[123] S. Ganta,et al. A review of stimuli-responsive nanocarriers for drug and gene delivery. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[124] D. S. Lee,et al. Stimulus‐Sensitive Polymeric Nanoparticles and Their Applications as Drug and Gene Carriers , 2013, Advanced healthcare materials.
[125] M. Tan,et al. Targeting cellular metabolism to improve cancer therapeutics , 2013, Cell Death and Disease.
[126] Omid C Farokhzad,et al. Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. , 2012, Chemical Society reviews.
[127] Angel Ortega,et al. Glutathione in Cancer Biology and Therapy , 2006, Critical reviews in clinical laboratory sciences.
[128] S. Bhatia,et al. Protease-triggered unveiling of bioactive nanoparticles. , 2008, Small.
[129] D. Hwang,et al. Phospholipase signalling networks in cancer , 2012, Nature Reviews Cancer.
[130] P. Allavena,et al. Cancer-related inflammation , 2008, Nature.
[131] X. Qi,et al. Enhancing cellular uptake of activable cell-penetrating peptide–doxorubicin conjugate by enzymatic cleavage , 2012, International journal of nanomedicine.
[132] Sylvia Notenboom,et al. Glutathione dysregulation and the etiology and progression of human diseases , 2009, Biological chemistry.
[133] Manish Kohli,et al. Nanoparticles for combination drug therapy. , 2013, ACS nano.
[134] Lin Zhu,et al. Matrix metalloprotease 2-responsive multifunctional liposomal nanocarrier for enhanced tumor targeting. , 2012, ACS nano.
[135] I. Aoki,et al. Hydrothermally synthesized PEGylated calcium phosphate nanoparticles incorporating Gd-DTPA for contrast enhanced MRI diagnosis of solid tumors. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[136] T. Shimada,et al. Impact of polyplex micelles installed with cyclic RGD peptide as ligand on gene delivery to vascular lesions , 2011, Gene Therapy.
[137] K. Chennazhi,et al. Dual drug encapsulated thermo-sensitive fibrinogen-graft-poly (N-isopropyl acrylamide) nanogels for breast cancer therapy. , 2014, Colloids and surfaces. B, Biointerfaces.
[138] J. Arias,et al. Drug targeting strategies in cancer treatment: an overview. , 2011, Mini reviews in medicinal chemistry.
[139] D. Irvine,et al. In vitro and in vivo mRNA delivery using lipid-enveloped pH-responsive polymer nanoparticles. , 2011, Molecular pharmaceutics.
[140] K. Huh,et al. Heparin-folate-retinoic acid bioconjugates for targeted delivery of hydrophobic photosensitizers. , 2013, Carbohydrate polymers.
[141] Chi-Hwa Wang,et al. Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment. , 2013, Biomaterials.
[142] Emily Waltz,et al. It's official: biologics are pharma's darlings , 2014, Nature Biotechnology.
[143] S. Davaran,et al. Development of dual responsive nanocomposite for simultaneous delivery of anticancer drugs , 2014, Journal of drug targeting.
[144] Ambika Bumb,et al. Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics. , 2010, Chemical reviews.
[145] R. Zhuo,et al. Theranostic GO-based nanohybrid for tumor induced imaging and potential combinational tumor therapy. , 2014, Small.
[146] Paul H. Johnson,et al. pH-responsive polymeric micelle carriers for siRNA drugs. , 2010, Biomacromolecules.
[147] Xiaogang Qu,et al. Bioresponsive hyaluronic acid-capped mesoporous silica nanoparticles for targeted drug delivery. , 2013, Chemistry.
[148] Robert Langer,et al. Nanoparticle delivery of cancer drugs. , 2012, Annual review of medicine.
[149] V. S. Lin,et al. A magnetic mesoporous silica nanoparticle-based drug delivery system for photosensitive cooperative treatment of cancer with a mesopore-capping agent and mesopore-loaded drug. , 2013, Nanoscale.
[150] Chen Jiang,et al. Tumor-targeting and microenvironment-responsive smart nanoparticles for combination therapy of antiangiogenesis and apoptosis. , 2013, ACS nano.
[151] S. W. Kim,et al. Paclitaxel-conjugated PEG and arginine-grafted bioreducible poly (disulfide amine) micelles for co-delivery of drug and gene. , 2012, Biomaterials.
[152] Emanuel Fleige,et al. Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications. , 2012, Advanced drug delivery reviews.
[153] T. Segura,et al. Protease degradable tethers for controlled and cell-mediated release of nanoparticles in 2- and 3-dimensions. , 2010, Biomaterials.
[154] M. Stevens,et al. Enzyme‐Responsive Nanoparticle Systems , 2008 .
[155] S. Biswas,et al. Hypoxia-targeted siRNA delivery. , 2014, Angewandte Chemie.
[156] Yue Zhao,et al. Main-chain photoresponsive polymers with controlled location of light-cleavable units: from synthetic strategies to structural engineering , 2013 .
[157] Changhui Li,et al. Enzyme-responsive copper sulphide nanoparticles for combined photoacoustic imaging, tumor-selective chemotherapy and photothermal therapy. , 2013, Chemical communications.
[158] F. Liu,et al. Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides. , 2013, Biomaterials.
[159] Po-Jung Chen,et al. Core‐Shell Nanocapsules Stabilized by Single‐Component Polymer and Nanoparticles for Magneto‐Chemotherapy/Hyperthermia with Multiple Drugs , 2012, Advanced materials.
[160] Sokindra Kumar,et al. Nanoparticles-mediated drug delivery approaches for cancer targeting: a review , 2013, Journal of drug targeting.
[161] K. Wooley,et al. Poly(ethylene oxide)‐block‐Polyphosphoester‐graft‐Paclitaxel Conjugates with Acid‐Labile Linkages as a pH‐Sensitive and Functional Nanoscopic Platform for Paclitaxel Delivery , 2014, Advanced healthcare materials.
[162] Vladimir P. Torchilin,et al. Recent Trends in Multifunctional Liposomal Nanocarriers for Enhanced Tumor Targeting , 2013, Journal of drug delivery.
[163] R. Costo,et al. INSTITUTE OF PHYSICS PUBLISHING JOURNAL OF PHYSICS D: APPLIED PHYSICS , 2003 .
[164] Duane D. Miller,et al. Site-specific delivery of oligonucleotides to hepatocytes after systemic administration. , 2008, Bioconjugate chemistry.
[165] S. Frokjaer,et al. Phospholipase A2 Sensitive Liposomes for Delivery of Small Interfering RNA (siRNA) , 2007, Journal of liposome research.
[166] Jun Li,et al. Supramolecular self-assembly forming a multifunctional synergistic system for targeted co-delivery of gene and drug. , 2014, Biomaterials.
[167] W. Degraff,et al. Selective modulation of glutathione levels in human normal versus tumor cells and subsequent differential response to chemotherapy drugs. , 1986, Cancer research.
[168] Jiaming Zhuang,et al. Multi-stimuli responsive macromolecules and their assemblies. , 2013, Chemical Society reviews.
[169] María J. Vicent,et al. Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines. , 2009, Advanced drug delivery reviews.
[170] P. Stayton,et al. Thermosensitive liposomes modified with poly(N-isopropylacrylamide-co-propylacrylic acid) copolymers for triggered release of doxorubicin. , 2010, Biomacromolecules.
[171] Ruth Duncan,et al. Development of HPMA copolymer-anticancer conjugates: clinical experience and lessons learnt. , 2009, Advanced drug delivery reviews.
[172] V. Torchilin,et al. Matrix metalloproteinase 2-sensitive multifunctional polymeric micelles for tumor-specific co-delivery of siRNA and hydrophobic drugs. , 2014, Biomaterials.
[173] Zheng Huang,et al. A Review of Progress in Clinical Photodynamic Therapy , 2005, Technology in cancer research & treatment.
[174] H. Padh,et al. Organelle targeting: third level of drug targeting , 2013, Drug design, development and therapy.
[175] Yun-Jaie Choi,et al. Synergistic effects of Akt1 shRNA and paclitaxel-incorporated conjugated linoleic acid-coupled poloxamer thermosensitive hydrogel on breast cancer. , 2012, Biomaterials.
[176] Fong-Yu Cheng,et al. Near‐Infrared Light‐Responsive Intracellular Drug and siRNA Release Using Au Nanoensembles with Oligonucleotide‐Capped Silica Shell , 2012, Advanced materials.
[177] Chih-Kuang Chen,et al. Biodegradable cationic polymeric nanocapsules for overcoming multidrug resistance and enabling drug-gene co-delivery to cancer cells. , 2014, Nanoscale.
[178] V. Torchilin,et al. Enhanced anticancer activity of nanopreparation containing an MMP2-sensitive PEG-drug conjugate and cell-penetrating moiety , 2013, Proceedings of the National Academy of Sciences.
[179] B. Sumerlin,et al. Future perspectives and recent advances in stimuli-responsive materials , 2010 .